Author Index Volume 48 (2015)
Abdelnour, C., see Alegret, M. (4) 1109-1117
Abe, K., see Matsuzono, K. (1) 279-286
Abe, K., see Matsuzono, K. (3) 757-763
Åberg, D., P. Johansson, J. Isgaard, A. Wallin, J.-O. Johansson, U. Andreasson, K. Blennow, H. Zetterberg, N.D. Åberg and J. Svensson, Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer’s Disease (3) 637-646
Åberg, N.D., see Åberg, D. (3) 637-646
Abisambra, J.F., see Meier, S. (3) 687-702
Akuffo, K.O., see Kelly, D. (1) 261-277
Alafuzoff, I., see Laiterä, T. (4) 959-968
Alafuzoff, I., see Popova, S.N. (3) 597-601
Alam, J.J., Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats (1) 219-227
Alegret, M., O. Rodríguez, A. Espinosa, G. Ortega, A. Sanabria, S. Valero, I. Hernández, M. Rosende-Roca, L. Vargas, C. Abdelnour, A. Mauleón, A. Gailhajanet, E. Martín, L. Tárraga, D.M. Rentz, R.E. Amariglio, A. Ruíz and M. Boada, Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects (4) 1109-1117
Alexander, M., G. Perera, L. Ford, H.M. Arrighi, N. Foskett, C. Debove, G. Novak and M.F. Gordon, Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review (2) 355-359
Alexopoulos, G.S., see Kiosses, D.N. (2) 453-462
Allinquant, B., see Moreno, L. (4) 927-935
Amariglio, R.E., see Alegret, M. (4) 1109-1117
Ambasta, R.K., see Jha, N.K. (4) 891-917
Ament, C., see Reddy, P.H. (2) 547-561
Amenta, F., see Rea, R. (2) 377-383
Ames, D., see Leifert, W.R. (2) 443-452
Ames, D., see Li, Q.-X. (1) 175-187
Amin, N.D., see Binukumar, B.K. (4) 1009-1017
Amin, S.M., see Hilal, S. (3) 813-823
Anderkova, L., I. Eliasova, R. Marecek, E. Janousova and I. Rektorova, Distinct Pattern of Gray Matter Atrophy in Mild Alz-heimer’s Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation (1) 251-260
Andreasson, U., see Åberg, D. (3) 637-646
Andrieu, S., see Di Stefano, F. (3) 793-804
Annas, P., see Matsunaga, S. (2) 403-410
Arias-Carrión, O., see Menéndez-González, M. (3) 581-589
Arrighi, H.M., see Alexander, M. (2) 355-359
Arrospide, A., see Soto-Gordoa, M. (3) 721-730
Arzberger, T., see Liu, J. (1) 55-58
Ashford, J.W., L. Mahoney and T. Burkett, A Role for Complementary and Integrative Medicine in Alzheimer’s Disease Prevention (1) 13-14
Awissus, C., see Weise, D. (2) 425-432
Bäckman, K., E. Joas, M. Waern, S. Östling, X. Guo, K. Blennow, I. Skoog and D.R. Gustafson, 37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden (4) 1119-1127
Bakardjian, H., see Di Stefano, F. (3) 793-804
Baker, L.D., see Hanson, A.J. (1) 205-218
Barberger-Gateau, P., see Shatenstein, B. (1) 35-53
Barbosa, M.T., see Fraga, V.G. (4) 1077-1081
Barkhof, F., see Brueggen, K. (1) 197-204
Barkhof, F., see Duits, F.H. (3) 711-720
Bartha, R., see Snir, J.A. (1) 73-87
Barthel, H., see Weise, D. (2) 425-432
Basun, H., see Eriksdotter, M. (3) 805-812
Basun, H., see Matsunaga, S. (2) 403-410
Battino, M., see Pistollato, F. (2) 303-318
Bayer, J.L., see Hanson, A.J. (1) 205-218
Beatty, S., see Kelly, D. (1) 261-277
Bekris, L.M., see Foraker, J. (3) 745-755
Bell, J.S., see Törmälehto, S.M. (4) 1033-1041
Bell, M., see Meier, S. (3) 687-702
Benito-León, J., see Serna, A. (1) 163-173
Benke, T., see Pertl, M.-T. (3) 765-779
Berger, E., see Chopard, G. (2) 385-393
Bermejo-Pareja, F., see Serna, A. (1) 163-173
Berres, M., see Mistridis, P. (4) 1095-1107
Beydoun, H.A., see Beydoun, M.A. (2) 361-375
Beydoun, M.A., H.A. Beydoun, A.A. Gamaldo, O.S. Rostant, G.A. Dore, A.B. Zonderman and S.M. Eid, Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer’s Disease among Older Adults in the United States, 2002–2012 (2) 361-375
Bhaskar, M., see Binukumar, B.K. (4) 1009-1017
Bielarczyk, H., A. Jankowska-Kulawy, C. Höfling, A. Ronowska, S. Gul-Hinc, S. Roßner, R. Schliebs, T. Pawelczyk and A. Szutowicz, AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer’s Disease (4) 1083-1094
Bilello, M., J. Doshi, S.A. Nabavizadeh, J.B. Toledo, G. Erus, S.X. Xie, J.Q. Trojanowski, X. Han and C. Davatzikos, Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer’s Disease (4) 987-994
Billard, J.-M., see Moreno, L. (4) 927-935
Binetruy, M., see Chopard, G. (2) 385-393
Binukumar, B.K., V. Shukla, N.D. Amin, M. Bhaskar, S. Skuntz, J. Steiner, D. Winkler, S.L. Pelech and H.C. Pant, Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein (4) 1009-1017
Blackmon, J., see Reddy, P.H. (2) 547-561
Blennow, K., see Åberg, D. (3) 637-646
Blennow, K., see Bäckman, K. (4) 1119-1127
Boada, M., see Alegret, M. (4) 1109-1117
Boles, A., see Reddy, P.H. (2) 547-561
Borroni, B., see Guido, D. (3) 703-709
Boucau, M.-C., see Kuntz, M. (3) 849-862
Brueggen, K., M. Dyrba, F. Barkhof, L. Hausner, M. Filippi, P.J. Nestor, K. Hauenstein, S. Klöppel, M.J. Grothe, E. Kasper, S.J. Teipel and the EDSD study group, Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer’s Disease in Patients with Mild Cognitive Impairment – A Multicenter DTI and Volumetry Study (1) 197-204
Brumback, B., see Price, C.C. (3) 833-847
Brundin, R.-M., see Söllvander, S. (1) 63-72
Burkett, T., see Ashford, J.W. (1) 13-14
Buschke, H., see Gramunt, N. (3) 613-625
Cacciafesta, M., see Servello, A. (2) 395-402
Cai, H., see Zheng, W. (4) 995-1008
Calderón-Garcidueñas, L., A. Mora-Tiscareño, G. Melo-Sánchez, J. Rodríguez-Díaz, R. Torres-Jardón, M. Styner, P.S. Mukherjee, W. Lin and V. Jewells, A Critical Proton MR Spectroscopy Marker of Alzheimer’s Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents (4) 1065-1075
Caltagirone, C., see Spalletta, G. (3) 627-636
Camí, J., see Gramunt, N. (3) 613-625
Candela, P., see Kuntz, M. (3) 849-862
Cano, S.S., see Pistollato, F. (2) 303-318
Cantet, C., see Di Stefano, F. (3) 793-804
Cao, Y., see Guo, Z. (3) 603-611
Caramelli, P., see Fraga, V.G. (4) 1077-1081
Carotenuto, A., see Rea, R. (2) 377-383
Carvalho, M.G., see Fraga, V.G. (4) 1077-1081
Castilla, I., see Soto-Gordoa, M. (3) 721-730
Cederholm, T., see Eriksdotter, M. (3) 805-812
Cermakova, P., K. Johnell, J. Fastbom, S. Garcia-Ptacek, L.H. Lund, B. Winblad, M. Eriksdotter and D. Religa, Cardiovascular Diseases in "30,000 Patients in the Swedish Dementia Registry (4) 949-958
Chen, C., see Hilal, S. (3) 813-823
Chen, H., see Liao, X. (2) 463-472
Chen, J., see Meier, S. (3) 687-702
Chen, K., see Hu, S. (3) 673-686
Chen, Q.-Y., see Zhang, X.-F. (1) 89-104
Chen, S., see Conejero-Goldberg, C. (4) 969-978
Chen, S., see Foraker, J. (3) 745-755
Chen, W., see Guo, Z. (3) 603-611
Chen, X., see Guo, Z. (3) 603-611
Chen, Y., see Zhang, S. (3) 781-791
Cheng, P., see Hu, S. (3) 673-686
Chiodo, L.A., see You, S.C. (3) 863-869
Choi, S.H., see Kim, H.J. (4) 1043-1050
Cholerton, B., see Hanson, A.J. (1) 205-218
Chopard, G., M. Puyraveau, M. Binetruy, A. Meyer, P. Vandel, E. Magnin, E. Berger, J. Galmiche and F. Mauny, Spectrum Effect and Spectrum Bias in the Screening Test Performance for Amnestic Mild Cognitive Impairment: What are the Clinical Implications? (2) 385-393
Coen, R.F., see Kelly, D. (1) 261-277
Coley, N., see Di Stefano, F. (3) 793-804
Collins, S., see Li, Q.-X. (1) 175-187
Conejero-Goldberg, C., T.M. Hyde, S. Chen, M.M. Herman, J.E. Kleinman, P. Davies and T.E. Goldberg, Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer’s Disease: Patterns of Protection and Degeneration (4) 969-978
Contador, I., see Serna, A. (1) 163-173
Craft, S., see Hanson, A.J. (1) 205-218
Cui, R., see Zhang, S. (3) 781-791
Dalli, J., see Fiala, M. (2) 293-301
Darby, D., see Li, Q.-X. (1) 175-187
Davatzikos, C., see Bilello, M. (4) 987-994
Davies, P., see Conejero-Goldberg, C. (4) 969-978
De Belder, F., see Struyfs, H. (4) 937-948
De Belder, M., see Struyfs, H. (4) 937-948
de Celis Alonso, B., see Menéndez-González, M. (3) 581-589
Debove, C., see Alexander, M. (2) 355-359
Deguchi, K., see Matsuzono, K. (1) 279-286
Deguchi, K., see Matsuzono, K. (3) 757-763
Delazer, M., see Pertl, M.-T. (3) 765-779
Dennison, J., see Kelly, D. (1) 261-277
Di Biasi, C., see Servello, A. (2) 395-402
Di Stefano, F., S. Epelbaum, N. Coley, C. Cantet,
P.-J. Ousset, H. Hampel, H. Bakardjian, S. Lista, B. Vellas, B. Dubois, S. Andrieu and for the GuidAge study group, Prediction of Alzheimer’s Disease Dementia: Data from the GuidAge Prevention Trial (3) 793-804
Diéguez-Vide, F., see Gramunt, N. (3) 613-625
Diehl-Wiesenecker, E., C.A.F. von Armin, L. Dupuis, H.-P. Müller, A.C. Ludolph and J. Kassubek, Adipose Tissue Distribution in Patients with Alzheimer’s Disease: A Whole Body MRI Case-Control Study (3) 825-832
Dinov, I.D., see Moon, S.W. (4) 1051-1063
Doecke, J.D., see Li, Q.-X. (1) 175-187
Donohue, M.C., see Hanson, A.J. (1) 205-218
Dore, G.A., see Beydoun, M.A. (2) 361-375
Doshi, J., see Bilello, M. (4) 987-994
Dubner, L., J. Wang, L. Ho, L. Ward and G.M. Pasinetti, Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer’s Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging (4) 879-889
Dubois, B., see Di Stefano, F. (3) 793-804
Duits, F.H., M. Hernandez-Guillamon, J. Montaner, J.D.C. Goos, A. Montañola, M.P. Wattjes, F. Barkhof, P. Scheltens, C.E. Teunissen and W.M. van der Flier, Matrix Metalloproteinases in Alzheimer’s Disease and Concurrent Cerebral Microbleeds (3) 711-720
Dupuis, L., see Diehl-Wiesenecker, E. (3) 825-832
Dutar, P., see Moreno, L. (4) 927-935
Dyrba, M., see Brueggen, K. (1) 197-204
Eid, S.M., see Beydoun, M.A. (2) 361-375
Ekholm-Pettersson, F., see Söllvander, S. (1) 63-72
El Haj, M., M.-C. Gély-Nargeot and S. Raffard, Destination Memory and Cognitive Theory of Mind in Alzheimer’s Disease (2) 529-536
Eliasova, I., see Anderkova, L. (1) 251-260
Elio, I., see Pistollato, F. (2) 303-318
Ellis, K.A., see Li, Q.-X. (1) 175-187
Engelborghs, S., see Struyfs, H. (4) 937-948
Epelbaum, S., see Di Stefano, F. (3) 793-804
Eriksdotter, M., I. Vedin, F. Falahati, Y. Freund-Levi, E. Hjorth, G. Faxen-Irving, L.-O. Wahlund, M. Schultzberg, H. Basun, T. Cederholm and J. Palmblad, Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer’s Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study (3) 805-812
Eriksdotter, M., see Cermakova, P. (4) 949-958
Eriksdotter, M., see Fereshtehnejad, S.-M. (1) 229-239
Eriksdotter, M., see Sarlus, H. (2) 495-505
Erus, G., see Bilello, M. (4) 987-994
Espinosa, A., see Alegret, M. (4) 1109-1117
Ettorre, E., see Servello, A. (2) 395-402
Evered, L.A., see Li, Q.-X. (1) 175-187
Eyjolfsdottir, H., see Sarlus, H. (2) 495-505
Faghihi, M.A., see Magistri, M. (3) 647-665
Falahati, F., see Eriksdotter, M. (3) 805-812
Fan, G.-H., see Zhang, X.-F. (1) 89-104
Fasanaro, A.M., see Rea, R. (2) 377-383
Fastbom, J., see Cermakova, P. (4) 949-958
Fauria, K., see Gramunt, N. (3) 613-625
Faxen-Irving, G., see Eriksdotter, M. (3) 805-812
Fenart, L., see Kuntz, M. (3) 849-862
Fenech, M.F., see Leifert, W.R. (2) 443-452
Feng, S., see Liao, X. (2) 463-472
Fereshtehnejad, S.-M., P. Johannsen, G. Waldemar and M. Eriksdotter, Dementia Diagnosis, Treatment, and Care in Specialist Clinics in Two Scandinavian Countries: A Data Comparison between the Swedish Dementia Registry (SveDem) and the Danish Dementia Registry (1) 229-239
Fernández-Calvo, B., see Serna, A. (1) 163-173
Fiala, M., N. Terrando and J. Dalli, Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment (2) 293-301
Filippi, M., see Brueggen, K. (1) 197-204
Finn, B., see Gauthier, S. (2) 473-481
Fins, J.J., The Reagan Diaries Reconsidered (1) 59-61
Fioretti, A., see Servello, A. (2) 395-402
Fletcher, P., see Marshall, C.R. (4) 923-926
Fonzetti, P., see Kiosses, D.N. (2) 453-462
Foraker, J., S.P. Millard, L. Leong, Z. Thomson, S. Chen, C.D. Keene, L.M. Bekris and C.-E. Yu, The APOE Gene is Differentially Methylated in Alzheimer’s Disease (3) 745-755
Ford, L., see Alexander, M. (2) 355-359
Forrester, S.N., see Leoutsakos, J.-M.S. (2) 483-493
Foskett, N., see Alexander, M. (2) 355-359
Fowler, C.J., see Li, Q.-X. (1) 175-187
Fox, N.C., see Marshall, C.R. (4) 923-926
Fraga, V.G., H.C. Guimarães, V.P. Lara, A.L. Teixeira, M.T. Barbosa, M.G. Carvalho, P. Caramelli and K.B. Gomes, TGF-β1 Codon 10 T>C Polymorphism Influences Short-Term Functional and Cognitive Decline in Healthy Oldest-Old Individuals: The Pietà Study (4) 1077-1081
François, M., see Leifert, W.R. (2) 443-452
Freund-Levi, Y., see Eriksdotter, M. (3) 805-812
Friede, T., see Schmidt, C. (1) 189-196
Fry, D., see Reddy, P.H. (2) 547-561
Fusetti, M., see Servello, A. (2) 395-402
Gailhajanet, A., see Alegret, M. (4) 1109-1117
Galmiche, J., see Chopard, G. (2) 385-393
Gamaldo, A.A., see Beydoun, M.A. (2) 361-375
Gao, S., see Hu, S. (3) 673-686
Gao, X., see Zheng, W. (4) 995-1008
Garcia-Ptacek, S., see Cermakova, P. (4) 949-958
Gauthier, S., S. Rountree, B. Finn, B. LaPlante, E. Weber and T. Oltersdorf, Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer’s Disease: A Randomized Phase 2 Study (2) 473-481
Ge, L.-J., see Zhang, X.-F. (1) 89-104
Gély-Nargeot, M.-C., see El Haj, M. (2) 529-536
Gensel, J.C., see Meier, S. (3) 687-702
Gerlach, N., see Schmidt, C. (1) 189-196
Gertz, H.-J., see Weise, D. (2) 425-432
Giaccone, G., The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer’s Disease (4) 919-921
Giampieri, F., see Pistollato, F. (2) 303-318
Gispert, J.D., see Gramunt, N. (3) 613-625
Goldberg, T.E., see Conejero-Goldberg, C. (4) 969-978
Gomes, K.B., see Fraga, V.G. (4) 1077-1081
Gonzales, R., see Reddy, P.H. (2) 547-561
Goos, J.D.C., see Duits, F.H. (3) 711-720
Gordon, M.F., see Alexander, M. (2) 355-359
Gosselet, F., see Kuntz, M. (3) 849-862
Gramunt, N., H. Buschke, G. Sánchez-Benavides, R.B. Lipton, J. Peña-Casanova, F. Diéguez-Vide, X. Masramon, J.D. Gispert, K. Fauria, J. Camí and J.L. Molinuevo, Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer’s and Family) (3) 613-625
Greig, N.H., see Karnati, H.K. (3) 563-580
Grothe, M.J., see Brueggen, K. (1) 197-204
Gualdi, G., see Servello, A. (2) 395-402
Guerreiro, R., see Marshall, C.R. (4) 923-926
Guido, D., G. Morandi, F. Palluzzi and B. Borroni, Telling the Story of Frontotemporal Dementia by Bibliometric Analysis (3) 703-709
Guimarães, H.C., see Fraga, V.G. (4) 1077-1081
Gul-Hinc, S., see Bielarczyk, H. (4) 1083-1094
Guo, X., see Bäckman, K. (4) 1119-1127
Guo, Z., see Liao, X. (2) 463-472
Guo, Z., X. Liu, X. Jia, H. Hou, Y. Cao, F. Wei, J. Li, X. Chen, Y. Zhang, Y. Shen, L. Wei, L. Xu and W. Chen, Regional Coherence Changes in Alzheimer’s Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study (3) 603-611
Gustafson, D.R., see Bäckman, K. (4) 1119-1127
Gutti, R.K., see Karnati, H.K. (3) 563-580
Haapasalo, A., see Laiterä, T. (4) 959-968
Haapasalo, A., see Sarajärvi, T. (2) 507-516
Hallikainen, I.T., see Törmälehto, S.M. (4) 1033-1041
Hallikainen, M., see Törmälehto, S.M. (4) 1033-1041
Hamaguchi, T., see Samuraki, M. (2) 517-528
Hampel, H., see Di Stefano, F. (3) 793-804
Hampel, H., see Matsunaga, S. (2) 403-410
Han, H.J., see Kim, H.J. (4) 1043-1050
Han, X., see Bilello, M. (4) 987-994
Hanson, A.J., J.L. Bayer, L.D. Baker, B. Cholerton, B. VanFossen, E. Trittschuh, R.A. Rissman, M.C. Donohue, S.H. Moghadam, S.R. Plymate and S. Craft, Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipo-protein E ɛ4 Carriers and Adults with Mild Cognitive Impairment (1) 205-218
Harris, E.A., see Harris, S.A. (2) 319-353
Harris, S.A. and E.A. Harris, Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease (2) 319-353
Hartikainen, S., see Heiskanen, J. (1) 241-249
Hauenstein, K., see Brueggen, K. (1) 197-204
Hausner, L., see Brueggen, K. (1) 197-204
He, B., see Liao, X. (2) 463-472
Heilman, K.M., see Price, C.C. (3) 833-847
Heiskanen, J., S. Hartikainen, R.P. Roine and A.-M. Tolppanen, 30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer’s Disease (1) 241-249
Helisalmi, S., see Laiterä, T. (4) 959-968
Helisalmi, S., see Sarajärvi, T. (2) 507-516
Herman, M.M., see Conejero-Goldberg, C. (4) 969-978
Hernández, I., see Alegret, M. (4) 1109-1117
Hernandez-Guillamon, M., see Duits, F.H. (3) 711-720
Hilal, S., S.M. Amin, N. Venketasubramanian, W.J. Niessen, H. Vrooman, T.Y. Wong, C. Chen and M.K. Ikram, Subcortical Atrophy in Cognitive Impairment and Dementia (3) 813-823
Hiltunen, M., see Laiterä, T. (4) 959-968
Hiltunen, M., see Sarajärvi, T. (2) 507-516
Hishikawa, N., see Matsuzono, K. (1) 279-286
Hishikawa, N., see Matsuzono, K. (3) 757-763
Hjorth, E., see Eriksdotter, M. (3) 805-812
Ho. L., see Dubner, L. (4) 879-889
Hobel, S., see Moon, S.W. (4) 1051-1063
Hodges, J.R., see Hutchings, R. (1) 135-147
Hoffmann, H., see Remington, R. (3) 591-595
Hoffmann, K.-T., see Weise, D. (2) 425-432
Höfling, C., see Bielarczyk, H. (4) 1083-1094
Hong, H.-S., I. Maezawa, J. Petrlova, X.-Y. Zhao, J.C. Voss and L.-W. Jin, Tomoregulin (TMEFF2) Binds Alzheimer’s Disease Amyloid-β (Aβ) Oligomer and AβPP and Protects Neurons from Aβ-Induced Toxicity (3) 731-743
Hort, J., see Kristofikova, Z. (1) 105-114
Hosono, T., A. Mouri, K. Nishitsuji, C.-G. Jung, M. Kontani, H. Tokuda, H. Kawashima, H. Shibata, T. Suzuki, T. Nabehsima and M. Michikawa, Arachidonic or Docosahexaenoic Acid Diet Prevents Memory Impairment in Tg2576 Mice (1) 149-162
Hou, H., see Guo, Z. (3) 603-611
Howard, A.N., see Kelly, D. (1) 261-277
Hu, B., see Zheng, W. (4) 995-1008
Hu, S., H. Wang, K. Chen, P. Cheng, S. Gao, J. Liu, X. Li and X. Sun, MicroRNA-34c Downregulation Ameliorates Amyloid-β-Induced Synaptic Failure and Memory Deficits by Targeting VAMP2 (3) 673-686
Huang, W.-J., see Zhang, X.-F. (1) 89-104
Hudson, R.H.E., see Snir, J.A. (1) 73-87
Hutchings, R., J.R. Hodges, O. Piguet and F. Kumfor, Why Should I Care? Dimensions of Socio-Emotional Cognition in Younger-Onset Dementia (1) 135-147
Hyde, T.M., see Conejero-Goldberg, C. (4) 969-978
Ibrahimi, S., see Keeney, J.T.-R. (2) 411-424
Ikram, M.K., see Hilal, S. (3) 813-823
Im, J.Y., see Kim, H.J. (4) 1043-1050
Ingram, A., see Meier, S. (3) 687-702
Isgaard, J., see Åberg, D. (3) 637-646
Iwata, N., see Kubo, M. (3) 667-671
Iwata, N., see Matsunaga, S. (2) 403-410
Jääskeläinen, J.E., see Laiterä, T. (4) 959-968
Jankowska-Kulawy, A., see Bielarczyk, H. (4) 1083-1094
Janousova, E., see Anderkova, L. (1) 251-260
Jeong, J.H., see Kim, H.J. (4) 1043-1050
Jewells, V., see Calderón-Garcidueñas, L. (4) 1065-1075
Jha, N.K., S.K. Jha, D. Kumar, N. Kejriwal, R. Sharma, R.K. Ambasta and P. Kumar, Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications (4) 891-917
Jha, S.K., see Jha, N.K. (4) 891-917
Jia, X., see Guo, Z. (3) 603-611
Jin, L.-W., see Hong, H.-S. (3) 731-743
Jin, Y., see Liao, X. (2) 463-472
Joas, E., see Bäckman, K. (4) 1119-1127
Johannsen, P., see Fereshtehnejad, S.-M. (1) 229-239
Johansson, J., see Kemppainen, N. (1) 123-133
Johansson, J.-O., see Åberg, D. (3) 637-646
Johansson, P., see Åberg, D. (3) 637-646
Johnell, K., see Cermakova, P. (4) 949-958
Joutsa, J., see Kemppainen, N. (1) 123-133
Jung, C.-G., see Hosono, T. (1) 149-162
Kaiser, T., see Weise, D. (2) 425-432
Kandimalla, R., see Reddy, P.H. (2) 547-561
Karnati, H.K., M.K. Panigrahi, R.K. Gutti, N.H. Greig and I.A. Tamargo, miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy (3) 563-580
Kasper, E., see Brueggen, K. (1) 197-204
Kassubek, J., see Diehl-Wiesenecker, E. (3) 825-832
Katirtzoglou, E.A., see Siarkos, K.T. (1) 15-34
Kauppinen, T., see Sarajärvi, T. (2) 507-516
Kawashima, H., see Hosono, T. (1) 149-162
Kaye, J.A., see Wood, P.L. (2) 537-546
Keene, C.D., see Foraker, J. (3) 745-755
Keeney, J.T.-R., S. Ibrahimi and L. Zhao, Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer’s Disease Prevention and Early Intervention (2) 411-424
Kejriwal, N., see Jha, N.K. (4) 891-917
Kelly, D., R.F. Coen, K.O. Akuffo, S. Beatty, J. Dennison, R. Moran, J. Stack, A.N. Howard, R. Mulcahy and J.M. Nolan, Cogni-tive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Ca-rotenoids (1) 261-277
Kemppainen, N., J. Joutsa, J. Johansson, N.M. Scheinin, K. Någren, J. Rokka, R. Parkkola and J.O. Rinne, Long-Term In-terrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment (1) 123-133
Ketelle, R., see You, S.C. (3) 863-869
Khalsa, D.S., Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands (1) 1-12
Kilander, L., see Söllvander, S. (1) 63-72
Kim, E.-J., see Kim, H.J. (4) 1043-1050
Kim, H.J., K.W. Park, T.E. Kim, J.Y. Im, H.S. Shin, S. Kim, D.H. Lee, B.S. Ye, J.H. Kim, E.-J. Kim, K.H. Park, H.J. Han, J.H. Jeong, S.H. Choi and S.A. Park, Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer’s Disease (4) 1043-1050
Kim, J., see Moon, S.W. (4) 1051-1063
Kim, J.H., see Kim, H.J. (4) 1043-1050
Kim, S., see Kim, H.J. (4) 1043-1050
Kim, T.E., see Kim, H.J. (4) 1043-1050
Kiosses, D.N., P.B. Rosenberg, A. McGovern, P. Fonzetti, H. Zaydens and G.S. Alexopoulos, Depression and Suicidal Ideation During Two Psychosocial Treatments in Older Adults with Major Depression and Dementia (2) 453-462
Kishi, T., see Kubo, M. (3) 667-671
Kishi, T., see Matsunaga, S. (2) 403-410
Klaschka, J., see Kristofikova, Z. (1) 105-114
Kleinman, J.E., see Conejero-Goldberg, C. (4) 969-978
Klöppel, S., see Brueggen, K. (1) 197-204
Knapik-Czajka, M., see Lewczuk, P. (2) 433-441
Koivisto, A.M., see Törmälehto, S.M. (4) 1033-1041
Kono, S., see Matsuzono, K. (1) 279-286
Kono, S., see Matsuzono, K. (3) 757-763
Kontani, M., see Hosono, T. (1) 149-162
Kornhuber, J., see Lewczuk, P. (2) 433-441
Kramer, J.H., see You, S.C. (3) 863-869
Kramer, K., see Schmidt, C. (1) 189-196
Kristensen, G., see Sparre-Sørensen, M. (4) 979-985
Kristofikova, Z., J. Ricny, M. Vyhnalek, J. Hort,
J. Laczo, J. Sirova, J. Klaschka and D. Ripova, Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias (1) 105-114
Krumm, S., see Mistridis, P. (4) 1095-1107
Krupski, W., see Papuć, E. (1) 115-121
Kubo, M., T. Kishi, S. Matsunaga and N. Iwata, Histamine H3 Receptor Antagonists for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials (3) 667-671
Kumar, D., see Jha, N.K. (4) 891-917
Kumar, P., see Jha, N.K. (4) 891-917
Kumfor, F., see Hutchings, R. (1) 135-147
Kuntz, M., P. Candela, J. Saint-Pol, Y. Lamartinière, M.-C. Boucau, E. Sevin, L. Fenart and F. Gosselet, Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier (3) 849-862
Kurki, M.I., see Laiterä, T. (4) 959-968
Kuruva, C.S., see Reddy, P.H. (2) 547-561
Kurys-Denis, E., see Papuć, E. (1) 115-121
Laczo, J., see Kristofikova, Z. (1) 105-114
Laiterä, T., M.I. Kurki, J.-P. Pursiheimo, H. Zetterberg, S. Helisalmi, T. Rauramaa, I. Alafuzoff, A.M. Remes, H. Soininen, A. Haapasalo, J.E. Jääskeläinen, M. Hiltunen and V. Leinonen, The Expression of Transthyretin and Amyloid-β Protein Precursor is Altered in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients (4) 959-968
Laitinen, M., see Sarajärvi, T. (2) 507-516
Lamartinière, Y., see Kuntz, M. (3) 849-862
Lannfelt, L., see Söllvander, S. (1) 63-72
LaPlante, B., see Gauthier, S. (2) 473-481
Lara, V.P., see Fraga, V.G. (4) 1077-1081
Laughton, K.M., see Li, Q.-X. (1) 175-187
Laws, S.M., see Li, Q.-X. (1) 175-187
Le, W., see Liu, H. (4) 1019-1032
Lee, D.H., see Kim, H.J. (4) 1043-1050
Leifert, W.R., T. Nguyen, A. Rembach, R. Martins, S. Rainey-Smith, C.L. Masters, D. Ames, C.C. Rowe, S.L. Macaulay, M. François, M.F. Fenech and the Australian Imaging, Biomarkers and Lifestyle Study Research Group, Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer’s Disease Risk (2) 443-452
Leinonen, V., see Laiterä, T. (4) 959-968
Leinonen, V., see Sarajärvi, T. (2) 507-516
Leong, L., see Foraker, J. (3) 745-755
Leoutsakos, J.-M.S., S.N. Forrester, C.G. Lyketsos and G.S. Smith, Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia (2) 483-493
Lewczuk, P., J. Kornhuber on behalf of the German Dementia Competence Network, J.B. Toledo, J.Q. Trojanowski, M. Knapik-Czajka, O. Peters, J. Wiltfang and L.M. Shaw on behalf of the US-ADNI, Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer’s Disease in Pre-Dementia Subjects (2) 433-441
Li, G., see Liao, X. (2) 463-472
Li, J., see Guo, Z. (3) 603-611
Li, Q.-X., V.L. Villemagne, J.D. Doecke, A. Rembach, S. Sarros, S. Varghese, A. McGlade, K.M. Laughton, K.K. Pertile, C.J. Fowler, R.L. Rumble, B.O. Trounson, K. Taddei, S.R. Rainey-Smith, S.M. Laws, J.S. Robertson, L.A. Evered, B. Silbert, K.A. Ellis, C.C. Rowe, S.L. Macaulay, D. Darby, R.N. Martins, D. Ames, C.L. Masters, S. Collins and for the AIBL Research Group, Alzheimer’s Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study (1) 175-187
Li, R.-S., see Zhang, X.-F. (1) 89-104
Li, X., see Hu, S. (3) 673-686
Li, X., see Zhang, S. (3) 781-791
Liao, X., G. Li, A. Wang, T. Liu, S. Feng, Z. Guo, Q. Tang, Y. Jin, G. Xing, M.A. McClure, H. Chen, B. He, H. Liu and Q. Mu, Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer’s Disease: A Meta-Analysis (2) 463-472
Libon, D.J., see Price, C.C. (3) 833-847
Lin, W., see Calderón-Garcidueñas, L. (4) 1065-1075
Lipton, R.B., see Gramunt, N. (3) 613-625
Lista, S., see Di Stefano, F. (3) 793-804
Liu, H., H. Qiu, Q. Xiao and W. Le, Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer’s Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model (4) 1019-1032
Liu, H., see Liao, X. (2) 463-472
Liu, J., M.-w. Zhu, T. Arzberger and L.-n. Wang, Frontotemporal Lobar Degeneration with Accumulation of Argyrophilic Grains and Lewy Bodies: A Clinicopathological Report (1) 55-58
Liu, J., see Hu, S. (3) 673-686
Liu, T., see Liao, X. (2) 463-472
Liu, X., see Guo, Z. (3) 603-611
Liu, Z., see Zhang, S. (3) 781-791
Lobsien, D., see Weise, D. (2) 425-432
Long, J.D., see Spalletta, G. (3) 627-636
Lortie, J.J., see Remington, R. (3) 591-595
Ludolph, A.C., see Diehl-Wiesenecker, E. (3) 825-832
Lund, L.H., see Cermakova, P. (4) 949-958
Luo, Y., see Zhang, X.-F. (1) 89-104
Lyketsos, C.G., see Leoutsakos, J.-M.S. (2) 483-493
Lyons, D.N., see Meier, S. (3) 687-702
Macaulay, S.L., see Leifert, W.R. (2) 443-452
Macaulay, S.L., see Li, Q.-X. (1) 175-187
Maezawa, I., see Hong, H.-S. (3) 731-743
Magistri, M., D. Velmeshev, M. Makhmutova and M.A. Faghihi, Transcriptomics Profiling of Alzheimer’s Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAs (3) 647-665
Magnin, E., see Chopard, G. (2) 385-393
Mahoney, L., see Ashford, J.W. (1) 13-14
Makhmutova, M., see Magistri, M. (3) 647-665
Mäkinen, P., see Sarajärvi, T. (2) 507-516
Manczak, M., see Reddy, P.H. (2) 547-561
Manzo, V., see Rea, R. (2) 377-383
Mar, J., see Soto-Gordoa, M. (3) 721-730
Marecek, R., see Anderkova, L. (1) 251-260
Marigliano, V., see Servello, A. (2) 395-402
Marshall, C.R., R. Guerreiro, S. Thust, P. Fletcher, J.D. Rohrer and N.C. Fox, A Novel MAPT Mutation Causing Corticobasal Syndrome Led by Progressive Apraxia of Speech (4) 923-926
Martikainen, J.A., see Törmälehto, S.M. (4) 1033-1041
Martín, E., see Alegret, M. (4) 1109-1117
Martínez-Lage, P., see Soto-Gordoa, M. (3) 721-730
Martins, R., see Leifert, W.R. (2) 443-452
Martins, R.N., see Li, Q.-X. (1) 175-187
Marttinen, M., see Sarajärvi, T. (2) 507-516
Masedu, F., see Servello, A. (2) 395-402
Masramon, X., see Gramunt, N. (3) 613-625
Masters, C.L., see Leifert, W.R. (2) 443-452
Masters, C.L., see Li, Q.-X. (1) 175-187
Matsunaga, S., see Kubo, M. (3) 667-671
Matsunaga, S., T. Kishi, P. Annas, H. Basun, H. Hampel and N. Iwata, Lithium as a Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2) 403-410
Matsunari, I., see Samuraki, M. (2) 517-528
Matsuzono, K., K. Sato, S. Kono, N. Hishikawa, Y. Ohta, T. Yamashita, K. Deguchi, Y. Nakano and K. Abe, Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS) (3) 757-763
Matsuzono, K., N. Hishikawa, T. Yamashita, Y. Ohta, K. Sato, S. Kono, K. Deguchi, R. Morihara and K. Abe, Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer’s Disease (oFTD Study) (1) 279-286
Mauleón, A., see Alegret, M. (4) 1109-1117
Mauny, F., see Chopard, G. (2) 385-393
McClure, M.A., see Liao, X. (2) 463-472
McGlade, A., see Li, Q.-X. (1) 175-187
McGovern, A., see Kiosses, D.N. (2) 453-462
Medicherla, S., see Wood, P.L. (2) 537-546
Meier, S., M. Bell, D.N. Lyons, A. Ingram, J. Chen, J.C. Gensel, H. Zhu, P.T. Nelson and J.F. Abisambra, Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer’s Disease Brain (3) 687-702
Melo- Sánchez, G., see Calderón-Garcidueñas, L. (4) 1065-1075
Menéndez-González, M., B. de Celis Alonso, J. Salas-Pacheco and O. Arias-Carrión, Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer’s Disease Clinical Trials (3) 581-589
Meyer, A., see Chopard, G. (2) 385-393
Michikawa, M., see Hosono, T. (1) 149-162
Millard, S.P., see Foraker, J. (3) 745-755
Miller, B.L., see You, S.C. (3) 863-869
Mistridis, P., S. Krumm, A.U. Monsch, M. Berres and K.I. Taylor, The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer’s Disease: The Temporal Emergence of Cognitive Decline (4) 1095-1107
Mitchell, A.J., see Serna, A. (1) 163-173
Moghadam, S.H., see Hanson, A.J. (1) 205-218
Mohanraj, A., see Moreno, L. (4) 927-935
Molinar-Lopez, V., see Reddy, P.H. (2) 547-561
Molinuevo, J.L., see Gramunt, N. (3) 613-625
Monsch, A.U., see Mistridis, P. (4) 1095-1107
Montaner, J., see Duits, F.H. (3) 711-720
Montañola, A., see Duits, F.H. (3) 711-720
Moon, S.W., I.D. Dinov, J. Kim, A. Zamanyan, S. Hobel, P.M. Thompson, A.W. Toga and for the Alzheimer’s Disease Neuroimaging Initiative, Structural Neuroimaging Genetics Interactions in Alzheimer’s Disease (4) 1051-1063
Moore, P., see Zheng, W. (4) 995-1008
Moran, R., see Kelly, D. (1) 261-277
Morandi, G., see Guido, D. (3) 703-709
Mora-Tiscareño, A., see Calderón-Garcidueñas, L. (4) 1065-1075
Moreno, L., C. Rose, A. Mohanraj, B. Allinquant, J.-M. Billard and P. Dutar, sAβPPα Improves Hippocampal NMDA-Dependent Functional Alterations Linked to Healthy Aging (4) 927-935
Moreno-Izco, F., see Soto-Gordoa, M. (3) 721-730
Morihara, R., see Matsuzono, K. (1) 279-286
Morrell, C., see Remington, R. (3) 591-595
Mouri, A., see Hosono, T. (1) 149-162
Mu, Q., see Liao, X. (2) 463-472
Mukherjee, P.S., see Calderón-Garcidueñas, L. (4) 1065-1075
Mulcahy, R., see Kelly, D. (1) 261-277
Müller, H.-P., see Diehl-Wiesenecker, E. (3) 825-832
Nabavizadeh, S.A., see Bilello, M. (4) 987-994
Nabehsima, T., see Hosono, T. (1) 149-162
Någren, K., see Kemppainen, N. (1) 123-133
Nakano, Y., see Matsuzono, K. (3) 757-763
Natunen, T., see Sarajärvi, T. (2) 507-516
Nelson, P.T., see Meier, S. (3) 687-702
Nestor, P.J., see Brueggen, K. (1) 197-204
Nguyen, T., see Leifert, W.R. (2) 443-452
Niessen, W.J., see Hilal, S. (3) 813-823
Nishitsuji, K., see Hosono, T. (1) 149-162
Noguchi-Shinohara, M., see Samuraki, M. (2) 517-528
Nolan, J.M., see Kelly, D. (1) 261-277
Novak, G., see Alexander, M. (2) 355-359
Ohta, Y., see Matsuzono, K. (1) 279-286
Ohta, Y., see Matsuzono, K. (3) 757-763
Oltersdorf, T., see Gauthier, S. (2) 473-481
Ono, K., see Samuraki, M. (2) 517-528
Oprica, M., see Sarlus, H. (2) 495-505
Orfei, M.D., see Spalletta, G. (3) 627-636
Ortega, G., see Alegret, M. (4) 1109-1117
Osborn, C., see Reddy, P.H. (2) 547-561
Östling, S., see Bäckman, K. (4) 1119-1127
Ousset, P.-J., see Di Stefano, F. (3) 793-804
Page, R., see Remington, R. (3) 591-595
Pagliarella, M., see Servello, A. (2) 395-402
Palluzzi, F., see Guido, D. (3) 703-709
Palmblad, J., see Eriksdotter, M. (3) 805-812
Pandey, A., see Reddy, P.H. (2) 547-561
Panigrahi, M.K., see Karnati, H.K. (3) 563-580
Pant, H.C., see Binukumar, B.K. (4) 1009-1017
Papuć, E., E. Kurys-Denis, W. Krupski, M. Tatara and K. Rejdak, Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer’s Disease? (1) 115-121
Parizel, P.M., see Struyfs, H. (4) 937-948
Park, K.H., see Kim, H.J. (4) 1043-1050
Park, K.W., see Kim, H.J. (4) 1043-1050
Park, S.A., see Kim, H.J. (4) 1043-1050
Parkkola, R., see Kemppainen, N. (1) 123-133
Pasinetti, G.M., see Dubner, L. (4) 879-889
Pasternak, S.H., see Snir, J.A. (1) 73-87
Paulie, S., see Söllvander, S. (1) 63-72
Pavaci, S., see Servello, A. (2) 395-402
Pawelczyk, T., see Bielarczyk, H. (4) 1083-1094
Pelech, S.L., see Binukumar, B.K. (4) 1009-1017
Peña-Casanova, J., see Gramunt, N. (3) 613-625
Perera, G., see Alexander, M. (2) 355-359
Pertile, K.K., see Li, Q.-X. (1) 175-187
Pertl, M.-T., T. Benke, L. Zamarian and M. Delazer, Decision Making and Ratio Processing in Patients with Mild Cognitive Impairment (3) 765-779
Pesälä, S., see Popova, S.N. (3) 597-601
Petäjä-Repo, U., see Sarajärvi, T. (2) 507-516
Peters, B., see Struyfs, H. (4) 937-948
Peters, O., see Lewczuk, P. (2) 433-441
Petrlova, J., see Hong, H.-S. (3) 731-743
Phillipps, A., see Wood, P.L. (2) 537-546
Piguet, O., see Hutchings, R. (1) 135-147
Pistollato, F., S.S. Cano, I. Elio, M.M. Vergara, F. Giampieri and M. Battino, The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer’s Disease (2) 303-318
Pittalis, A., see Servello, A. (2) 395-402
Pizzoli, S., see Spalletta, G. (3) 627-636
Plymate, S.R., see Hanson, A.J. (1) 205-218
Politis, A.M., see Siarkos, K.T. (1) 15-34
Popova, S.N., S. Pesälä and I. Alafuzoff, To Stage Alzheimer’s Disease Related Neurodegeneration Using one Section of Hippocampus (3) 597-601
Price, C.C., J.J. Tanner, I.M. Schmalfuss, B. Brumback, K.M. Heilman and D.J. Libon, Dissociating Statistically-Determined Alzheimer’s Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters (3) 833-847
Pursiheimo, J.-P., see Laiterä, T. (4) 959-968
Puyraveau, M., see Chopard, G. (2) 385-393
Qiu, H., see Liu, H. (4) 1019-1032
Quesada, K., see Reddy, P.H. (2) 547-561
Quinn, J.F., see Wood, P.L. (2) 537-546
Raffard, S., see El Haj, M. (2) 529-536
Rainey-Smith, S., see Leifert, W.R. (2) 443-452
Rainey-Smith, S.R., see Li, Q.-X. (1) 175-187
Ramos, F., see Serna, A. (1) 163-173
Rauramaa, T., see Laiterä, T. (4) 959-968
Rauramaa, T., see Sarajärvi, T. (2) 507-516
Rea, R., A. Carotenuto, E. Traini, A.M. Fasanaro, V. Manzo and F. Amenta, Apathy Treatment in Alzheimer’s Disease: Interim Results of the ASCOMALVA Trial (2) 377-383
Reddy, P.H., J. Blackmon, V. Molinar-Lopez, C. Ament, M. Manczak, R. Kandimalla, X. Yin, A. Pandey, C.S. Kuruva, R. Wang, D. Fry, C. Osborn, K. Stonum, K. Quesada, R. Gonzales and A. Boles, Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer’s Disease (2) 547-561
Rejdak, K., see Papuć, E. (1) 115-121
Rektorova, I., see Anderkova, L. (1) 251-260
Religa, D., see Cermakova, P. (4) 949-958
Rembach, A., see Leifert, W.R. (2) 443-452
Rembach, A., see Li, Q.-X. (1) 175-187
Remes, A.M., see Laiterä, T. (4) 959-968
Remington, R., J.J. Lortie, H. Hoffmann, R. Page, C. Morrell and T.B. Shea, A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension (3) 591-595
Rentz, D.M., see Alegret, M. (4) 1109-1117
Ricny, J., see Kristofikova, Z. (1) 105-114
Rinne, J.O., see Kemppainen, N. (1) 123-133
Ripova, D., see Kristofikova, Z. (1) 105-114
Rissman, R.A., see Hanson, A.J. (1) 205-218
Robberecht, C., see Struyfs, H. (4) 937-948
Robertson, J.S., see Li, Q.-X. (1) 175-187
Robinson, R.G., see Spalletta, G. (3) 627-636
Rodríguez, O., see Alegret, M. (4) 1109-1117
Rodríguez-Díaz, J., see Calderón-Garcidueñas, L. (4) 1065-1075
Rohrer, J.D., see Marshall, C.R. (4) 923-926
Roine, R.P., see Heiskanen, J. (1) 241-249
Rokka, J., see Kemppainen, N. (1) 123-133
Ronowska, A., see Bielarczyk, H. (4) 1083-1094
Rose, C., see Moreno, L. (4) 927-935
Rosenberg, P.B., see Kiosses, D.N. (2) 453-462
Rosende-Roca, M., see Alegret, M. (4) 1109-1117
Roßner, S., see Bielarczyk, H. (4) 1083-1094
Rostant, O.S., see Beydoun, M.A. (2) 361-375
Rountree, S., see Gauthier, S. (2) 473-481
Rowe, C.C., see Leifert, W.R. (2) 443-452
Rowe, C.C., see Li, Q.-X. (1) 175-187
Ruíz, A., see Alegret, M. (4) 1109-1117
Rumble, R.L., see Li, Q.-X. (1) 175-187
Sabri, O., see Weise, D. (2) 425-432
Saint-Pol, J., see Kuntz, M. (3) 849-862
Salas-Pacheco, J., see Menéndez-González, M. (3) 581-589
Samuraki, M., I. Matsunari, M. Yoshita, K. Shima, M. Noguchi-Shinohara, T. Hamaguchi, K. Ono and M. Yamada, Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer’s Disease (2) 517-528
Sanabria, A., see Alegret, M. (4) 1109-1117
Sánchez-Benavides, G., see Gramunt, N. (3) 613-625
Sarajärvi, T., M. Marttinen, T. Natunen, T. Kauppinen, P. Mäkinen, S. Helisalmi, M. Laitinen, T. Rauramaa, V. Leinonen, U. Petäjä-Repo, H. Soininen, A. Haapasalo and M. Hiltunen, Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer’s Disease (2) 507-516
Sarlus, H., H. Eyjolfsdottir, M. Eriksdotter, M. Oprica and M. Schultzberg, Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease (2) 495-505
Sarros, S., see Li, Q.-X. (1) 175-187
Sato, K., see Matsuzono, K. (1) 279-286
Sato, K., see Matsuzono, K. (3) 757-763
Scheinin, N.M., see Kemppainen, N. (1) 123-133
Scheltens, P., see Duits, F.H. (3) 711-720
Schliebs, R., see Bielarczyk, H. (4) 1083-1094
Schmalfuss, I.M., see Price, C.C. (3) 833-847
Schmidt, C., N. Gerlach, M. Schmitz, T. Thom, K. Kramer, T. Friede and I. Zerr, Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer’s Disease (1) 189-196
Schmitz, M., see Schmidt, C. (1) 189-196
Schultzberg, M., see Eriksdotter, M. (3) 805-812
Schultzberg, M., see Sarlus, H. (2) 495-505
Sehlin, D., see Söllvander, S. (1) 63-72
Serna, A., I. Contador, F. Bermejo-Pareja, A.J. Mitchell, B. Fernández-Calvo, F. Ramos, A. Villarejo and J. Beni-to-León, Accuracy of a Brief Neuropsychological Battery for the Diagnosis of Dementia and Mild Cognitive Im-pairment: An Analysis of the NEDICES Cohort (1) 163-173
Servello, A., A. Fioretti, G. Gualdi, C. Di Biasi, A. Pittalis, S. Sollaku, S. Pavaci, F. Tortorella, M. Fusetti, M. Valenti, F. Masedu, M. Cacciafesta, V. Marigliano, E. Ettorre and M. Pagliarella, Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer’s Disease: Is There a Correlation? A Pilot Study (2) 395-402
Sevin, E., see Kuntz, M. (3) 849-862
Sharma, R., see Jha, N.K. (4) 891-917
Shatenstein, B. and P. Barberger-Gateau, Prevention of Age-Related Cognitive Decline: Which Strategies, When, and for Whom? (1) 35-53
Shaw, L.M., see Lewczuk, P. (2) 433-441
Shea, T.B., see Remington, R. (3) 591-595
Sheikh, N., see Wood, P.L. (2) 537-546
Shen, Y., see Guo, Z. (3) 603-611
Shibata, H., see Hosono, T. (1) 149-162
Shima, K., see Samuraki, M. (2) 517-528
Shin, H.S., see Kim, H.J. (4) 1043-1050
Shukla, V., see Binukumar, B.K. (4) 1009-1017
Siarkos, K.T., E.A. Katirtzoglou and A.M. Politis, A Review of Pharmacological Treatments for Depression in Alzheimer’s Disease (1) 15-34
Sijbers, J., see Struyfs, H. (4) 937-948
Silbert, B., see Li, Q.-X. (1) 175-187
Sirova, J., see Kristofikova, Z. (1) 105-114
Skoog, I., see Bäckman, K. (4) 1119-1127
Skuntz, S., see Binukumar, B.K. (4) 1009-1017
Slaets, S., see Struyfs, H. (4) 937-948
Sleegers, K., see Struyfs, H. (4) 937-948
Smith, G.S., see Leoutsakos, J.-M.S. (2) 483-493
Snir, J.A., M. Suchy, K. St. Lawrence, R.H.E. Hudson, S.H. Pasternak and R. Bartha, Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer’s Disease (1) 73-87
Soininen, H., see Laiterä, T. (4) 959-968
Soininen, H., see Sarajärvi, T. (2) 507-516
Sollaku, S., see Servello, A. (2) 395-402
Söllvander, S., F. Ekholm-Pettersson, R.-M. Brundin, G. Westman, L. Kilander, S. Paulie, L. Lannfelt and D. Sehlin, In-creased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer’s Disease (1) 63-72
Soto-Gordoa, M., A. Arrospide, F. Moreno-Izco, P. Martínez-Lage, I. Castilla and J. Mar, Projecting Burden of Dementia in Spain, 2010–2050: Impact of Modifying Risk Factors (3) 721-730
Spalletta, G., J.D. Long, R.G. Robinson, A.Trequattrini, S. Pizzoli, C. Caltagirone and M.D. Orfei, Longitudinal Neuropsychiatric Predictors of Death in Alzheimer’s Disease (3) 627-636
Sparre-Sørensen, M. and G. Kristensen, Alzheimer’s Disease in the Danish Malnutrition Period 1999–2007 (4) 979-985
St. Lawrence, K., see Snir, J.A. (1) 73-87
Stack, J., see Kelly, D. (1) 261-277
Steiner, J., see Binukumar, B.K. (4) 1009-1017
Stonum, K., see Reddy, P.H. (2) 547-561
Struyfs, H., W. Van Hecke, J. Veraart, J. Sijbers, S. Slaets, M. De Belder, L. Wuyts, B. Peters, K. Sleegers, C. Robberecht, C. Van Broeckhoven, F. De Belder, P.M. Parizel and S. Engelborghs, Diffusion Kurtosis Imaging: A Possible MRI Biomarker for AD Diagnosis? (4) 937-948
Styner, M., see Calderón-Garcidueñas, L. (4) 1065-1075
Suchy, M., see Snir, J.A. (1) 73-87
Sun, M., see Zhang, X.-F. (1) 89-104
Sun, X., see Hu, S. (3) 673-686
Suzuki, T., see Hosono, T. (1) 149-162
Svensson, J., see Åberg, D. (3) 637-646
Szutowicz, A., see Bielarczyk, H. (4) 1083-1094
Taddei, K., see Li, Q.-X. (1) 175-187
Tamargo, I.A., see Karnati, H.K. (3) 563-580
Tang, Q., see Liao, X. (2) 463-472
Tanner, J.J., see Price, C.C. (3) 833-847
Tárraga, L., see Alegret, M. (4) 1109-1117
Tatara, M., see Papuć, E. (1) 115-121
Taylor, K.I., see Mistridis, P. (4) 1095-1107
Teipel, S.J., see Brueggen, K. (1) 197-204
Teixeira, A.L., see Fraga, V.G. (4) 1077-1081
Terrando, N., see Fiala, M. (2) 293-301
Terry, B., see Wood, P.L. (2) 537-546
Teunissen, C.E., see Duits, F.H. (3) 711-720
Thom, T., see Schmidt, C. (1) 189-196
Thompson, P.M., see Moon, S.W. (4) 1051-1063
Thomson, Z., see Foraker, J. (3) 745-755
Thust, S., see Marshall, C.R. (4) 923-926
Tiepolt, S., see Weise, D. (2) 425-432
Toga, A.W., see Moon, S.W. (4) 1051-1063
Tokuda, H., see Hosono, T. (1) 149-162
Toledo, J.B., see Bilello, M. (4) 987-994
Toledo, J.B., see Lewczuk, P. (2) 433-441
Tolppanen, A.-M., see Heiskanen, J. (1) 241-249
Törmälehto, S.M., J.A. Martikainen, S.T. Väätäinen, I.T. Hallikainen, M. Hallikainen, J.S. Bell, A.M. Koivisto and on the behalf of the ALSOVA study group, Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer’s Disease over a Three-Year Period: Kuopio ALSOVA Study (4) 1033-1041
Torres-Jardón, R., see Calderón-Garcidueñas, L. (4) 1065-1075
Tortorella, F., see Servello, A. (2) 395-402
Traini, E., see Rea, R. (2) 377-383
Trequattrini, A., see Spalletta, G. (3) 627-636
Trittschuh, E., see Hanson, A.J. (1) 205-218
Trojanowski, J.Q., see Bilello, M. (4) 987-994
Trojanowski, J.Q., see Lewczuk, P. (2) 433-441
Trounson, B.O., see Li, Q.-X. (1) 175-187
Väätäinen, S.T., see Törmälehto, S.M. (4) 1033-1041
Valenti, M., see Servello, A. (2) 395-402
Valero, S., see Alegret, M. (4) 1109-1117
Van Broeckhoven, C., see Struyfs, H. (4) 937-948
van der Flier, W.M., see Duits, F.H. (3) 711-720
Van Hecke, W., see Struyfs, H. (4) 937-948
Vandel, P., see Chopard, G. (2) 385-393
VanFossen, B., see Hanson, A.J. (1) 205-218
Vargas, L., see Alegret, M. (4) 1109-1117
Varghese, S., see Li, Q.-X. (1) 175-187
Vedin, I., see Eriksdotter, M. (3) 805-812
Vellas, B., see Di Stefano, F. (3) 793-804
Velmeshev, D., see Magistri, M. (3) 647-665
Venketasubramanian, N., see Hilal, S. (3) 813-823
Veraart, J., see Struyfs, H. (4) 937-948
Vergara, M.M., see Pistollato, F. (2) 303-318
Villarejo, A., see Serna, A. (1) 163-173
Villemagne, V.L., see Li, Q.-X. (1) 175-187
von Armin, C.A.F., see Diehl-Wiesenecker, E. (3) 825-832
Voss, J.C., see Hong, H.-S. (3) 731-743
Vrooman, H., see Hilal, S. (3) 813-823
Vyhnalek, M., see Kristofikova, Z. (1) 105-114
Waern, M., see Bäckman, K. (4) 1119-1127
Wahlund, L.-O., see Eriksdotter, M. (3) 805-812
Waldemar, G., see Fereshtehnejad, S.-M. (1) 229-239
Wallin, A., see Åberg, D. (3) 637-646
Walsh, C.M., see You, S.C. (3) 863-869
Wang, A., see Liao, X. (2) 463-472
Wang, H., see Hu, S. (3) 673-686
Wang, J., see Dubner, L. (4) 879-889
Wang, J.-F., see Zhang, X.-F. (1) 89-104
Wang, L.-n., see Liu, J. (1) 55-58
Wang, R., see Reddy, P.H. (2) 547-561
Ward, L., see Dubner, L. (4) 879-889
Wattjes, M.P., see Duits, F.H. (3) 711-720
Weber, E., see Gauthier, S. (2) 473-481
Wei, F., see Guo, Z. (3) 603-611
Wei, L., see Guo, Z. (3) 603-611
Weise, D., S. Tiepolt, C. Awissus, K.-T. Hoffmann, D. Lobsien, T. Kaiser, H. Barthel, O. Sabri and H.-J. Gertz, Critical Comparison of Different Biomarkers for Alzheimer’s Disease in a Clinical Setting (2) 425-432
Westman, G., see Söllvander, S. (1) 63-72
Wiltfang, J., see Lewczuk, P. (2) 433-441
Winblad, B., see Cermakova, P. (4) 949-958
Winkler, D., see Binukumar, B.K. (4) 1009-1017
Woltjer, R.L., see Wood, P.L. (2) 537-546
Wong, T.Y., see Hilal, S. (3) 813-823
Wood, P.L., S. Medicherla, N. Sheikh, B. Terry, A. Phillipps, J.A. Kaye, J.F. Quinn and R.L. Woltjer, Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer’s Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer’s Disease (2) 537-546
Wuyts, L., see Struyfs, H. (4) 937-948
Xiao, Q., see Liu, H. (4) 1019-1032
Xiao, Z.-C., see Zhang, X.-F. (1) 89-104
Xie, S.X., see Bilello, M. (4) 987-994
Xing, G., see Liao, X. (2) 463-472
Xu, L., see Guo, Z. (3) 603-611
Yamada, M., see Samuraki, M. (2) 517-528
Yamashita, T., see Matsuzono, K. (1) 279-286
Yamashita, T., see Matsuzono, K. (3) 757-763
Yao, Z., see Zheng, W. (4) 995-1008
Ye, B.S., see Kim, H.J. (4) 1043-1050
Yin, X., see Reddy, P.H. (2) 547-561
Yoshita, M., see Samuraki, M. (2) 517-528
You, S.C., C.M. Walsh, L.A. Chiodo, R. Ketelle, B.L. Miller and J.H. Kramer, Neuropsychiatric Symptoms Predict Functional Status in Alzheimer’s Disease (3) 863-869
Yu, C.-E., see Foraker, J. (3) 745-755
Zamanyan, A., see Moon, S.W. (4) 1051-1063
Zamarian, L., see Pertl, M.-T. (3) 765-779
Zaydens, H., see Kiosses, D.N. (2) 453-462
Zerr, I., see Schmidt, C. (1) 189-196
Zetterberg, H., see Åberg, D. (3) 637-646
Zetterberg, H., see Laiterä, T. (4) 959-968
Zhang, J., see Zhang, S. (3) 781-791
Zhang, S., Y. Chen, Z. Liu, J. Zhang, X. Li, R. Cui and Z. Zhang, Association of White Matter Integrity and Cognitive Functions in Chinese Non-Demented Elderly with the APOE ɛ4 Allele (3) 781-791
Zhang, X.-F., Y.-F. Zhao, S.-W. Zhu, W.-J. Huang, Y. Luo, Q.-Y. Chen, L.-J. Ge, R.-S. Li, J.-F. Wang, M. Sun, Z.-C. Xiao and G.-H. Fan, CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer’s Disease (1) 89-104
Zhang, Y., see Guo, Z. (3) 603-611
Zhang, Z., see Zhang, S. (3) 781-791
Zhao, L., see Keeney, J.T.-R. (2) 411-424
Zhao, X.-Y., see Hong, H.-S. (3) 731-743
Zhao, Y.-F., see Zhang, X.-F. (1) 89-104
Zheng, W., Z. Yao, B. Hu, X. Gao, H. Cai, P. Moore and for the Alzheimer’s Disease Neuroimaging Initiative, Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer’s Disease (4) 995-1008
Zhu, H., see Meier, S. (3) 687-702
Zhu, M.-w., see Liu, J. (1) 55-58
Zhu, S.-W., see Zhang, X.-F. (1) 89-104
Zonderman, A.B., see Beydoun, M.A. (2) 361-375
